{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:01:23Z","timestamp":1786975283593,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1124\/dmd.117.079277","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T15:50:13Z","timestamp":1519228213000},"page":"704-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition"],"prefix":"10.1016","volume":"46","author":[{"given":"Jennifer","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan E.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie P.","family":"Volak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert T.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.079277_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/intv.21296","article-title":"Quantitative intravital microscopy of hepatic transport","volume":"1","author":"Babbey","year":"2012","journal-title":"IntraVital"},{"key":"10.1124\/dmd.117.079277_bib2","first-page":"G382","article-title":"Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells","volume":"266","author":"Boyer","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.117.079277_bib3","doi-asserted-by":"crossref","first-page":"G522","DOI":"10.1152\/ajpgi.2000.278.4.G522","article-title":"MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells","volume":"278","author":"Cantz","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.117.079277_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.117.079277_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1124\/dmd.117.079277_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079277_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/jpet.110.166991","article-title":"Hepatic transport mechanisms of cholyl-l-lysyl-fluorescein","volume":"334","author":"de Waart","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.079277_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ymeth.2017.04.015","article-title":"Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats","volume":"128","author":"Dunn","year":"2017","journal-title":"Methods"},{"key":"10.1124\/dmd.117.079277_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.079277_bib10","doi-asserted-by":"crossref","unstructured":"Feng B, Xu JJ, Bi YA, Mireles R, Davidson R, Duignan DB, Campbell S, Kostrubsky VE, Dunn MC, Smith AR, Wang HF (2009) Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714. Toxicol Sci 108:492\u2013500.","DOI":"10.1093\/toxsci\/kfp033"},{"key":"10.1124\/dmd.117.079277_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(02)00107-1","article-title":"Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan","volume":"37","author":"Fouassier","year":"2002","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.117.079277_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-483X(01)00460-7","volume":"167","author":"Funk","year":"2001","journal-title":"Toxicology"},{"key":"10.1124\/dmd.117.079277_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(24)12255-9","article-title":"Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat","volume":"59","author":"Funk","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.117.079277_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.510280231","article-title":"Transport of fluorescent bile acids by the isolated perfused rat liver: kinetics, sequestration, and mobilization","volume":"28","author":"Holzinger","year":"1998","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.079277_bib15","first-page":"1263","article-title":"Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat","volume":"26","author":"Holzinger","year":"1997","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.079277_bib16","doi-asserted-by":"crossref","unstructured":"Jemnitz K, Veres Z, Vereczkey L (2010) Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human. Toxicol Sci 115:80\u201388.","DOI":"10.1093\/toxsci\/kfq044"},{"key":"10.1124\/dmd.117.079277_bib17","doi-asserted-by":"crossref","unstructured":"Kostrubsky VE, Strom SC, Hanson J, Urda E, Rose K, Burliegh J, Zocharski P, Cai H, Sinclair JF, Sahi J (2003) Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol Sci 76:220\u2013228.","DOI":"10.1093\/toxsci\/kfg217"},{"key":"10.1124\/dmd.117.079277_bib18","doi-asserted-by":"crossref","unstructured":"Kostrubsky SE, Strom SC, Kalgutkar AS, Kulkarni S, Atherton J, Mireles R, Feng B, Kubik R, Hanson J, Urda E, Mutlib AE (2006) Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. Toxicol Sci 90:451\u2013459.","DOI":"10.1093\/toxsci\/kfj095"},{"key":"10.1124\/dmd.117.079277_bib19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/hep.24548","article-title":"Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes","volume":"54","author":"Kruglov","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.079277_bib20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.079277_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/gen.35.07.08","article-title":"Quantifying efflux activity in 3D liver spheroids","volume":"35","author":"Letzsch","year":"2015","journal-title":"Genet Eng Biotechnol News"},{"key":"10.1124\/dmd.117.079277_bib22","first-page":"637","article-title":"Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets","volume":"22","author":"Maglova","year":"1995","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.079277_bib23","series-title":"Optical Microscopy for Biology","first-page":"357","article-title":"Studies of endocytosis using image intensification fluorescence microscopy and digital image analysis","author":"Maxfield","year":"1990"},{"key":"10.1124\/dmd.117.079277_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0168-8278(99)80348-1","article-title":"Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: a study in isolated hepatocyte couplets and TR\u2212 rats","volume":"31","author":"Mills","year":"1999","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.117.079277_bib25","first-page":"447","article-title":"Cholyllysyl fluroscein and related lysyl fluorescein conjugated bile acid analogues","volume":"70","author":"Mills","year":"1997","journal-title":"Yale J Biol Med"},{"key":"10.1124\/dmd.117.079277_bib26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","article-title":"Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs","volume":"34","author":"Mita","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.079277_bib27","doi-asserted-by":"crossref","unstructured":"Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW Jr, Lightfoot-Dunn R, Hamadeh HK (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118:485\u2013500.","DOI":"10.1093\/toxsci\/kfq269"},{"key":"10.1124\/dmd.117.079277_bib28","doi-asserted-by":"crossref","unstructured":"Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT 2nd, Afshari CA, Hamadeh HK (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci 136:216\u2013241.","DOI":"10.1093\/toxsci\/kft176"},{"key":"10.1124\/dmd.117.079277_bib29","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1124\/dmd.117.079277_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/dmd.117.079277_bib31","doi-asserted-by":"crossref","first-page":"R1488","DOI":"10.1152\/ajpregu.00371.2014","article-title":"Effects of chronic kidney disease on liver transport: quantitative intravital microscopy of fluorescein transport in the rat liver","volume":"307","author":"Ryan","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/dmd.117.079277_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00424-006-0152-8","article-title":"The bile salt export pump","volume":"453","author":"Stieger","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.117.079277_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.117.079277_bib34","first-page":"Unit 23 25","article-title":"Membrane vesicle ABC transporter assays for drug safety assessment","volume":"Chapter 23","author":"van Staden","year":"2012","journal-title":"Curr Protoc Toxicol"},{"key":"10.1124\/dmd.117.079277_bib35","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.23089","article-title":"Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/dmd.117.079277_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fphar.2014.00240","article-title":"Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury","volume":"5","author":"Woodhead","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.117.079277_bib37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1124\/dmd.107.019398","article-title":"Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors","volume":"36","author":"Ye","year":"2008","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.079277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:35:07Z","timestamp":1739903707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624055107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0090955624055107"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.079277","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.079277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}